Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Thrombin-binding antibody molecules

Thrombin-binding antibody molecules

US Patent 9518128 · Granted Dec 13, 2016

Estimated economic value: $129,594,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2022
Thrombin-binding antibody molecules and uses thereof2021
Thrombin-binding antibody molecules and uses thereof2021
Thrombin-binding antibody molecules and uses thereof2021
Thrombin-binding antibody molecules and uses thereof2019
Thrombin-binding antibody molecules and uses thereof2019
Thrombin-binding antibody molecules and uses thereof2019
Modified serpins for the treatment of bleeding disorders2019